Please wait while the formulary information is being retrieved.
Drug overview for PROHANCE MULTIPACK (gadoteridol):
Generic name: GADOTERIDOL
Drug class:
Therapeutic class: Diagnostic Agents
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
Generic name: GADOTERIDOL
Drug class:
Therapeutic class: Diagnostic Agents
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
DRUG IMAGES
PROHANCE 279.3 MG/ML VIAL
The following indications for PROHANCE MULTIPACK (gadoteridol) have been approved by the FDA:
Indications:
Diagnostic imaging
Professional Synonyms:
Diagnostic imaging exam
Diagnostic imaging procedure
Diagnostic radiography
Diagnostic radiology
Indications:
Diagnostic imaging
Professional Synonyms:
Diagnostic imaging exam
Diagnostic imaging procedure
Diagnostic radiography
Diagnostic radiology
The following dosing information is available for PROHANCE MULTIPACK (gadoteridol):
No enhanced Dosing information available for this drug.
No enhanced Administration information available for this drug.
No dosing information available.
No generic dosing information available.
The following drug interaction information is available for PROHANCE MULTIPACK (gadoteridol):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for PROHANCE MULTIPACK (gadoteridol):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 3 contraindications.
Absolute contraindication.
| Contraindication List |
|---|
| Acute renal failure |
| Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min |
| Nephrogenic systemic fibrosis |
There are 1 severe contraindications.
Adequate patient monitoring is recommended for safer drug use.
| Severe List |
|---|
| Kidney disease with likely reduction in glomerular filtration rate (GFr) |
There are 1 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
| Moderate List |
|---|
| Asthma |
The following adverse reaction information is available for PROHANCE MULTIPACK (gadoteridol):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 27 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
| None. |
Dyspnea |
| Rare/Very Rare |
|---|
|
Acute pancreatitis Acute renal failure Acute respiratory distress syndrome Acute respiratory failure Anaphylaxis Angina Angioedema Atrioventricular block Bradycardia Bronchospastic pulmonary disease Cardiac arrhythmia Extravasation injury Facial edema Fatigue Hypersensitivity drug reaction Hypertension Hypoglycemic disorder Hypotension Increased alanine transaminase Increased aspartate transaminase Laryngeal edema Nephrogenic systemic fibrosis Pulmonary edema Seizure disorder Tachycardia Tongue swelling |
There are 37 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Dysgeusia Nausea Vomiting |
Acute cognitive impairment Diarrhea Dizziness Headache disorder Injection site erythema Injection site pain Pruritus of skin Symptoms of anxiety Urticaria |
| Rare/Very Rare |
|---|
|
Acute abdominal pain Anorexia Back pain Chest discomfort Eye tearing Eyelid edema Fever General weakness Gingival pain Gingivitis Injection site sequelae Muscle rigidity Ocular itching Oral pruritus Pain Palpitations Paresthesia Rhinitis Sensation of warmth Skin rash Syncope Tinnitus Tremor Vasodilation of blood vessels Xerostomia |
The following precautions are available for PROHANCE MULTIPACK (gadoteridol):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
No enhanced Pregnancy information available for this drug.
No enhanced Lactation information available for this drug.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for PROHANCE MULTIPACK (gadoteridol):
WARNING: This medication may rarely cause kidney damage. The risk of kidney damage is greater if you already have kidney problems, if you are an older adult, or if you have high blood pressure or diabetes. Your doctor should check how well your kidneys are working before you receive this medication. See also Side Effects section.
WARNING: This medication may rarely cause kidney damage. The risk of kidney damage is greater if you already have kidney problems, if you are an older adult, or if you have high blood pressure or diabetes. Your doctor should check how well your kidneys are working before you receive this medication. See also Side Effects section.
The following icd codes are available for PROHANCE MULTIPACK (gadoteridol)'s list of indications:
No ICD codes found for this drug.
No ICD codes found for this drug.
Formulary Reference Tool